This funding opportunity promotes the discovery and initial evaluation of candidate biomarkers and biomarker signatures for neurological and neuromuscular disorders. It supports research that includes biological, analytical, and clinical evaluation, with a requirement for preliminary human evaluation using standardized samples or datasets. The goal is to develop biomarkers ready for definitive validation studies, facilitating neurotherapeutic development and clinical use.
Eligible applicants include a wide range of U.S. entities such as governments, educational institutions, nonprofits, small businesses, and tribal organizations. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible.
